SleepCogni bolsters board for next phase of growth

Sheffield-based healthtech business SleepCogni has appointed two non-executive directors as it prepares for further NHS engagement and its next investment round.

Bryn Sage, former chief executive of digital healthcare specialist Inhealthcare, and Jason Brannan, former deputy director of Sheffield Hallam University’s Advanced Wellbeing Research Centre, have joined the board.

Bryn brings more than 40 years’ experience in developing and commercialising technology.

At Inhealthcare, he oversaw the rollout of four million episodes of digital care across 150 pathways, working with more than 50 NHS trusts and other health bodies.

He led the business until its acquisition by US medical technology company ResMed in 2024.

Bryn said: “With deep experience across respiratory health, cardiology and digital therapeutics, I’ve seen how well‑designed technology can shift outcomes at population scale. 

“Insomnia is an increasingly significant clinical and economic burden, and SleepCogni’s integrated bedside and wearable solution is differentiated in a way that genuinely matters. 

“I’m excited to support the team in driving adoption and commercial growth.”

Jason has more than 20 years’ experience across health technology and life sciences, spanning healthcare, academia and the public and private sectors.

He added: “SleepCogni's technology has the potential to make a real difference to the lives of people struggling with insomnia. 

“I’m excited to support the team as they move from strong clinical evidence into broader commercial success. 

“Over the past 20 years my focus has been on strategic growth in healthtech, helping ambitious companies turn promising science into products that reach the people who need them.”

The pair will work alongside chief executive Richard Mills as SleepCogni looks to commercialise its patented handheld sleep device following a period of research and clinical trials.

They join a board chaired by Colin Greene, a former Apple director and chief executive of Apple Korea.

Richard added: “Bryn and Jason bring exactly the experience we need as we move into our next phase of growth. 

“Bryn has been chief executive of leading digital health businesses, including one that exited to ResMed in 2024, operating directly in our space. 

“Jason led strategy at one of the UK's top wellbeing research centres and understands what it takes to get evidence-based health technology into widespread use. 

“Their commercial and clinical insight will strengthen our board significantly.”

Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →

Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.